Investor Relations
Our mission is simple—help patients across the globe who suffer from pain and chronic conditions. We are doing this by harnessing the power of nVNS, innovation, and technology to develop a safe and clinically backed treatment. Bringing new treatments to market will help improve patients' treatment options and lives.
SEC Filings
| Filing date | Description | Form | Filing Group | View |
|---|---|---|---|---|
Annual report which provides a comprehensive overview of the company for the past year |
10-K |
Annual Filings
|
EX-101.INS - XBRL INSTANCE DOCUMENT View HTML | |
Annual report which provides a comprehensive overview of the company for the past year |
10-K |
Annual Filings
|
EX-101.INS - XBRL INSTANCE DOCUMENT View HTML | |
Quarterly report which provides a continuing view of a company's financial position |
10-Q |
Quarterly Filings
|
EX-101.INS - XBRL INSTANCE DOCUMENT View HTML | |
Quarterly report which provides a continuing view of a company's financial position |
10-Q |
Quarterly Filings
|
EX-101.INS - XBRL INSTANCE DOCUMENT View HTML | |
Quarterly report which provides a continuing view of a company's financial position |
10-Q |
Quarterly Filings
|
EX-101.INS - XBRL INSTANCE DOCUMENT View HTML | |
Quarterly report which provides a continuing view of a company's financial position |
10-Q |
Quarterly Filings
|
EX-101.INS - XBRL INSTANCE DOCUMENT View HTML | |
Quarterly report which provides a continuing view of a company's financial position |
10-Q |
Quarterly Filings
|
EX-101.INS - XBRL INSTANCE DOCUMENT View HTML | |
Termination of registration under Section 12(g) or suspension of duty to file reports |
15-12B |
Other
|
View HTML | |
Initial filing by director officer or owner of more than ten percent. |
3 |
3,4,5
|
View HTML | |
Initial filing by director officer or owner of more than ten percent. |
3 |
3,4,5
|
View HTML |
Displaying 1 - 10 of 107 results
Data provided by Kaleidoscope.